Has Jefferson Morrison, MD received payments from drug or device companies?

Yes. Drug and device makers reported $677,835 in general payments to Jefferson Morrison, MD across 458 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jefferson Morrison, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jefferson Morrison, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jefferson Morrison, MD

Orthopaedic Surgery · Nashville, TNNPI 1609831916

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $428,092 of the $677,835 with a category attached, or 63.2%. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 46.8% of the total. Reporting peaked in 2023 at $222,077 and has fallen 62.5% since, to $83,273 in 2025. Among orthopaedic surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$677,835in general payments, 2019–2025

Across 458 payments — averaging $1479.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$317K
Depuy Synthes Products, Inc.$282K
Exactech, Inc.$62K
Johnson & Johnson$11K
Synthes GmbH$2K
Smith+Nephew$2K
plus $1K from 9 others

$308,288in research payments, 2019–2025

Across 181 payments — averaging $1703.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$162K
Exactech, Inc.$77K
Zimmer Biomet$65K
Conformis, Inc.$4K

What the payments were for

Royalty or licence$200,00030%
Consulting fees$428,09263%
Speaking & faculty fees$1,5000%
Travel & lodging$37,2495%
Food & beverage$10,9932%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	254	$317,445
Depuy Synthes Products, Inc.	95	$281,941
Exactech, Inc.	54	$62,070
Johnson & Johnson	24	$11,061
Synthes GmbH	3	$2,188
Smith+Nephew	15	$1,669
Brainlab, Inc.	2	$541
Medacta USA, Inc.	2	$254
Stryker	1	$159
Boston Scientific	2	$151
Restor3d, Inc.	1	$147
Mimedx Group, Inc.	1	$142
Ferring Pharmaceuticals Inc.	2	$29
Innovation Technologies Inc	1	$19
Onkos Surgical, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$677,835 in reported general payments places this provider in the 95th percentile of 381 orthopaedic surgery providers in Tennessee.

See all orthopaedic surgery providers in Tennessee →

Medicare billing

Part B allowed, 2024

$308,043

Medicare patients

409

Services billed

3,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tranexamic Acid	17	$431
Amoxicillin	102	$274
Oxycodone Hcl	43	$232
Diclofenac Sodium	11	$103
Pantoprazole Sodium	19	$90
Cephalexin	22	$89
Hydromorphone Hcl	12	$89
Meloxicam	37	$82
Celecoxib	11	$72
Tramadol Hcl	21	$45
Ondansetron Hcl	11	$36
Clindamycin Hcl	13	$31
Dexamethasone	16	$25
Prednisone	15	$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Nashville

Gregory PolkowskiNashville$526K
Matthew WillisNashville$498K
Michael ChristieNashville$474K
David DeboerNashville$448K
Rudolph GlattesNashville$444K
John MartinNashville$212K
Nicholas StrasserNashville$184K
Jeffrey HodrickNashville$173K
Brian DierckmanNashville$172K
Stephen EngstromNashville$149K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →